Edwards Lifesciences (EW) Work In Process (2010 - 2026)

Edwards Lifesciences' Work In Process history runs 13 years deep, the most recent figure standing at $242.2 million for Q1 2026.

• On a quarterly basis, Work In Process fell 6.92% year-over-year to $242.2 million in Q1 2026; TTM through Mar 2026 was $242.2 million, a 6.92% decrease from a year earlier, with the FY2025 full-year figure at $252.9 million, up 7.07% from the prior year.
• Work In Process eased to $242.2 million in Q1 2026 per EW's latest filing, from $252.9 million in the prior quarter.
• Across five years, Work In Process topped out at $275.9 million in Q3 2025 and bottomed at $195.8 million in Q4 2023.
• The 4-year median for Work In Process is $248.6 million (2024), against an average of $246.5 million.
• Across the five-year window, Work In Process climbed 20.63% in 2024 and declined 6.92% in 2026, its largest moves.
• Year by year, Work In Process stood at $195.8 million in 2023, then advanced by 20.63% to $236.2 million in 2024, then increased by 7.07% to $252.9 million in 2025, then retreated by 4.23% to $242.2 million in 2026.
• Per Business Quant, the three latest EW Work In Process figures stand at $242.2 million (Q1 2026), $252.9 million (Q4 2025), and $275.9 million (Q3 2025).